Apellis Pharmaceuticals, Inc. (APLS)

20.99 -0.65 (-3.00%) USD  |  NASDAQ  |  Feb 27, 14:13
More

Apellis Pharmaceuticals Return on Equity (3y Mean)

Return on Equity (3y Mean) Chart

View Return on Equity (3y Mean) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Equity (3y Mean) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Equity (3y Mean) Range, Past 5 Years

View Return on Equity (3y Mean) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Equity (3y Mean) Benchmarks

View Return on Equity (3y Mean) Benchmarks
Start Trial
Amneal Pharmaceuticals, Inc. --
Alnylam Pharmaceuticals, Inc. --
Amicus Therapeutics, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade